Aviva’s Probitas buy to bolster non-life margins through 2024

Shares in London-listed Aviva were muted in early trading on Monday despite positive analysts commentary after the UK insurer surprised the market with news it would once again build a presence in Lloyd’s through the £242mn acquisition of Probitas.


Want to read this article?


For details on how to subscribe or for all commercial opportunities, including advertising, please contact:

Spencer Halladey

Commercial director

+44 (0) 7540 000929


    Andy Stone

    Sales manager

    +44 (0) 77 4160 9204